Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipientsForat Lutfi, Maxim Norkin, Hemant S. Murthy et al.|Hematology/Oncology and Stem Cell Therapy|2019Cited by 18
Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant CenterForat Lutfi, Maxim Norkin, William Paul Skelton et al.|Blood|2017Cited by 3
Monitoring of GRAFT Versus Leukemia Effect with CD34+ Specific DONOR Chimerism AnalysisMaxim Norkin, John R. Wingard, Christopher R. Cogle et al.|Transplantation and Cellular Therapy|2014Cited by 0
Peripheral Blood CD34+ Specific Donor Chimerism Analysis As an Early Indicator of Disease Relapse After Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes and Acute Myelogenous Leukemia.Maxim Norkin, John R. Wingard, Amy Meacham et al.|Blood|2012Cited by 0
Clinical factors influencing engraftment in patients with non-Hodgkin lymphoma following autologous stem cell transplant.William Paul Skelton, Maxim Norkin, Forat Lutfi et al.|Journal of Clinical Oncology|2018Cited by 0